Combined Hydroxyethyl Starch Luteolin Nanocrystals for Effective Anti-Hyperuricemia Effect in Mice Model
DOI: https://doi.org/10.2147/ijn.s464948
IF: 7.033
2024-06-04
International Journal of Nanomedicine
Abstract:Han Luo, 1, &ast Xiaofei Wang, 1, &ast Mengqi Fang, 1 Huifan Yu, 1 Lili Gui, 1 Zhengkun Wu, 1 Jianyong Sheng, 2 Fei Li 1 1 Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China; 2 Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Li, Hubei University of Medicine, 30 Renmin South Road, Shiyan, Hubei, 442000, People's Republic of China, Email Introduction: Although flavonoid compounds exhibit various pharmacological activities, their clinical applications are restricted by low oral bioavailability owing to their poor solubility. Nanocrystals (NCs) represent an excellent strategy for enhancing the oral bioavailability of flavonoids. Hydroxyethyl starch (HES), a biomaterial compound used as a plasma expander, could be an ideal stabilizer material for preparing flavonoid NCs. Methods: HES was used to stabilize flavonoid nanocrystals (NCs), using luteolin (LUT) as a model drug. After full characterization, the freeze-drying and storage stability, solubility, intestinal absorption, pharmacokinetics, and in vivo anti-hyperuricemic effect of the optimized HES-stabilized LUT NCs (LUT-HES NCs) were investigated. Results: Uniformed LUT-HES NCs were prepared with mean particle size of 191.1± 16.8 nm, zeta potential of about − 23 mV, drug encapsulation efficiency of 98.52 ± 1.01%, and drug loading of 49.26 ± 0.50%. The freeze-dried LUT-HES NCs powder showed good re-dispersibility and storage stability for 9 months. Notably, compared with the coarse drug, LUT-HES NCs exhibited improved saturation solubility (7.49 times), increased drug dissolution rate, enhanced Caco-2 cellular uptake (2.78 times) and oral bioavailability (Fr=355.7%). Pharmacodynamic studies showed that LUT-HES NCs remarkably lowered serum uric acid levels by 69.93% and ameliorated renal damage in hyperuricemic mice. Conclusion: HES is a potential stabilizer for poorly soluble flavonoid NCs and provides a promising strategy for the clinical application of these compounds. LUT-HES NCs may be an alternative or complementary strategy for hyperuricemia treatment. Keywords: Hydroxyethyl starch, nanocrystals, stabilizer, luteolin, oral bioavailability, anti-hyperuricemia Flavonoids represent a class of secondary metabolites with polyphenol structure, such as luteolin, quercetin, rutin, hesperidin and phloretin, which are widely found in fruits, vegetables, tea and Chinese herbal medicine. 1,2 Flavonoids are generally characterized by the C6-C3-C6 basic skeleton, composed of two benzene rings with phenolic hydroxyl connected by a central chain of three-carbon atoms. 3,4 Due to the unique chemical structure, flavonoids possess a variety of activities including antioxidant, anti-inflammatory, anti-tumor, hypoglycemic, uric acid-lowering, antibacterial and antiviral properties, which play a vital role in maintaining human and animal health. 1,5–8 These natural compounds are a group of promising drug candidates that warrant further exploration. Unfortunately, the application of flavonoids in disease prevention and/or treatment is unsatisfactory, probably because of their poor aqueous solubility and limited oral bioavailability. 3,9–11 Nanocrystals (NCs), also called nanosuspensions, is a submicron colloidal dispersion system composed of "pure drugs" with stabilizer, which has been considered a brilliant strategy to enhance the oral bioavailability of insoluble active flavonoid components. 10,12,13 By directly reducing the particle size of these compounds to the nanometer range and thus enlarging their surface area, this strategy can increase the saturation solubility and dissolution velocity, eventually realizing improved bioavailability and expanding scope of application. 14–16 Stabilizer is generally required to prevent aggregation between high-energy crystal surfaces during size reduction during nanocrystals preparation. 17,18 However, there is no systematic screening rule for the types, dosage and prescription of stabilizers for flavonoid NCs, so the screening of stabilizers is mainly based on the exclusion method at present. 12,19 On the other hand, the commonly used stabilizers for nanosuspensions including sodium dodecyl sulfate and Tween 80 have the drawbacks of poor biocompatibility and chronic toxicity. 10,18,20 In addition, nanosuspensions are -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology